APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etoricoxib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Etoricoxib Industry Growth and Trends Forecast to 2032

2 January 2026104 pages

Choose your research edition.

Industry ResearchEtoricoxib Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Etoricoxib Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Etoricoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etoricoxib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Etoricoxib Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Etoricoxib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Etoricoxib include Shanghai Shyndec Pharmaceutical, Qilu Pharmaceutical, Merck & Co, Easton Biopharmaceuticals, Beijing Tide Pharmaceutical, Morepen Laboratories, Metrochem API, Hema Pharmaceuticals and Frosst Iberica SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Etoricoxib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Etoricoxib market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Etoricoxib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Etoricoxib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Etoricoxib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Etoricoxib Market by Company

Shanghai Shyndec Pharmaceutical

Qilu Pharmaceutical

Merck & Co

Easton Biopharmaceuticals

Beijing Tide Pharmaceutical

Morepen Laboratories

Metrochem API

Hema Pharmaceuticals

Frosst Iberica SA

Atom Pharma

Etoricoxib Segment by Type

120 mg

30 mg

60 mg

90 mg

Etoricoxib Segment by Application

Hospital

Pharmacy

Others

Etoricoxib Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoricoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etoricoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoricoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Etoricoxib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Etoricoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 120 mg Table 2. Major Company of 30 mg Table 3. Major Company of 60 mg Table 4. Major Company of 90 mg Table 5. Global Etoricoxib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Etoricoxib Sales by Type (2021-2026) & (K Units) Table 7. Global Etoricoxib Sales Market Share in Volume by Type (2021-2026) Table 8. Global Etoricoxib Sales by Type (2021-2026) & (US$ Million) Table 9. Global Etoricoxib Sales Market Share in Value by Type (2021-2026) Table 10. Global Etoricoxib Price by Type (2021-2026) & (US$/Unit) Table 11. Global Etoricoxib Sales by Type (2027-2032) & (K Units) Table 12. Global Etoricoxib Sales Market Share in Volume by Type (2027-2032) Table 13. Global Etoricoxib Sales by Type (2027-2032) & (US$ Million) Table 14. Global Etoricoxib Sales Market Share in Value by Type (2027-2032) Table 15. Global Etoricoxib Price by Type (2027-2032) & (US$/Unit) Table 16. North America Etoricoxib Sales by Type (2021-2026) & (K Units) Table 17. North America Etoricoxib Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Etoricoxib Sales by Type (2021-2026) & (K Units) Table 19. Europe Etoricoxib Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Etoricoxib Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Etoricoxib Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Etoricoxib Sales by Type (2021-2026) & (K Units) Table 23. Latin America Etoricoxib Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Etoricoxib Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Etoricoxib Sales by Type (2021-2026) & (US$ Million) Table 26. Etoricoxib Industry Trends Table 27. Etoricoxib Industry Drivers Table 28. Etoricoxib Industry Opportunities and Challenges Table 29. Etoricoxib Industry Restraints Table 30. Global Etoricoxib Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Etoricoxib Revenue Market Share by Company (2021-2026) Table 32. Global Etoricoxib Sales by Company (2021-2026) & (K Units) Table 33. Global Etoricoxib Sales Share by Company (2021-2026) Table 34. Global Etoricoxib Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Etoricoxib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Etoricoxib Major Company Production Sites and Headquarters Table 37. Global Etoricoxib Company, Product Type & Application Table 38. Global Etoricoxib Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Etoricoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Etoricoxib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Etoricoxib Sales by Region (2021-2026) & (K Units) Table 43. Global Etoricoxib Sales Market Share in Volume by Region (2021-2026) Table 44. Global Etoricoxib Sales by Region (2021-2026) & (US$ Million) Table 45. Global Etoricoxib Sales Market Share in Value by Region (2021-2026) Table 46. Global Etoricoxib Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Etoricoxib Sales by Region (2027-2032) & (K Units) Table 48. Global Etoricoxib Sales Market Share in Volume by Region (2027-2032) Table 49. Global Etoricoxib Sales by Region (2027-2032) & (US$ Million) Table 50. Global Etoricoxib Sales Market Share in Value by Region (2027-2032) Table 51. Global Etoricoxib Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Etoricoxib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Etoricoxib Sales by Application (2021-2026) & (K Units) Table 54. Global Etoricoxib Sales Market Share in Volume by Application (2021-2026) Table 55. Global Etoricoxib Sales by Application (2021-2026) & (US$ Million) Table 56. Global Etoricoxib Sales Market Share in Value by Application (2021-2026) Table 57. Global Etoricoxib Price by Application (2021-2026) & (US$/Unit) Table 58. Global Etoricoxib Sales by Application (2027-2032) & (K Units) Table 59. Global Etoricoxib Sales Market Share in Volume by Application (2027-2032) Table 60. Global Etoricoxib Sales by Application (2027-2032) & (US$ Million) Table 61. Global Etoricoxib Sales Market Share in Value by Application (2027-2032) Table 62. Global Etoricoxib Price by Application (2027-2032) & (US$/Unit) Table 63. North America Etoricoxib Sales by Application (2021-2026) & (K Units) Table 64. North America Etoricoxib Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Etoricoxib Sales by Application (2021-2026) & (K Units) Table 66. Europe Etoricoxib Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Etoricoxib Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Etoricoxib Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Etoricoxib Sales by Application (2021-2026) & (K Units) Table 70. Latin America Etoricoxib Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Etoricoxib Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Etoricoxib Sales by Application (2021-2026) & (US$ Million) Table 73. Shanghai Shyndec Pharmaceutical Company Information Table 74. Shanghai Shyndec Pharmaceutical Business Overview Table 75. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio Table 77. Shanghai Shyndec Pharmaceutical Recent Development Table 78. Qilu Pharmaceutical Company Information Table 79. Qilu Pharmaceutical Business Overview Table 80. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Qilu Pharmaceutical Etoricoxib Product Portfolio Table 82. Qilu Pharmaceutical Recent Development Table 83. Merck & Co Company Information Table 84. Merck & Co Business Overview Table 85. Merck & Co Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck & Co Etoricoxib Product Portfolio Table 87. Merck & Co Recent Development Table 88. Easton Biopharmaceuticals Company Information Table 89. Easton Biopharmaceuticals Business Overview Table 90. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Easton Biopharmaceuticals Etoricoxib Product Portfolio Table 92. Easton Biopharmaceuticals Recent Development Table 93. Beijing Tide Pharmaceutical Company Information Table 94. Beijing Tide Pharmaceutical Business Overview Table 95. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Beijing Tide Pharmaceutical Etoricoxib Product Portfolio Table 97. Beijing Tide Pharmaceutical Recent Development Table 98. Morepen Laboratories Company Information Table 99. Morepen Laboratories Business Overview Table 100. Morepen Laboratories Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Morepen Laboratories Etoricoxib Product Portfolio Table 102. Morepen Laboratories Recent Development Table 103. Metrochem API Company Information Table 104. Metrochem API Business Overview Table 105. Metrochem API Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Metrochem API Etoricoxib Product Portfolio Table 107. Metrochem API Recent Development Table 108. Hema Pharmaceuticals Company Information Table 109. Hema Pharmaceuticals Business Overview Table 110. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hema Pharmaceuticals Etoricoxib Product Portfolio Table 112. Hema Pharmaceuticals Recent Development Table 113. Frosst Iberica SA Company Information Table 114. Frosst Iberica SA Business Overview Table 115. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Frosst Iberica SA Etoricoxib Product Portfolio Table 117. Frosst Iberica SA Recent Development Table 118. Atom Pharma Company Information Table 119. Atom Pharma Business Overview Table 120. Atom Pharma Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Atom Pharma Etoricoxib Product Portfolio Table 122. Atom Pharma Recent Development Table 123. North America Etoricoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Etoricoxib Sales by Country (2021-2026) & (K Units) Table 125. North America Etoricoxib Sales Market Share by Country (2021-2026) Table 126. North America Etoricoxib Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Etoricoxib Sales Market Share Forecast by Country (2027-2032) Table 128. North America Etoricoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Etoricoxib Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Etoricoxib Market Share by Country (2021-2026) Table 131. North America Etoricoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Etoricoxib Market Share Forecast by Country (2027-2032) Table 133. Europe Etoricoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Etoricoxib Sales by Country (2021-2026) & (K Units) Table 135. Europe Etoricoxib Sales Market Share by Country (2021-2026) Table 136. Europe Etoricoxib Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Etoricoxib Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Etoricoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Etoricoxib Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Etoricoxib Market Share by Country (2021-2026) Table 141. Europe Etoricoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Etoricoxib Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Etoricoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Etoricoxib Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Etoricoxib Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Etoricoxib Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Etoricoxib Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Etoricoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Etoricoxib Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Etoricoxib Market Share by Country (2021-2026) Table 151. Asia-Pacific Etoricoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Etoricoxib Market Share Forecast by Country (2027-2032) Table 153. Latin America Etoricoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Etoricoxib Sales by Country (2021-2026) & (K Units) Table 155. Latin America Etoricoxib Sales Market Share by Country (2021-2026) Table 156. Latin America Etoricoxib Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Etoricoxib Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Etoricoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Etoricoxib Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Etoricoxib Market Share by Country (2021-2026) Table 161. Latin America Etoricoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Etoricoxib Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Etoricoxib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Etoricoxib Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Etoricoxib Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Etoricoxib Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Etoricoxib Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Etoricoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Etoricoxib Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Etoricoxib Market Share by Country (2021-2026) Table 171. Middle East and Africa Etoricoxib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Etoricoxib Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Etoricoxib Distributors List Table 176. Etoricoxib Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Etoricoxib Image Figure 2. Global Etoricoxib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etoricoxib Market Size (2021-2032) & (US$ Million) Figure 4. Global Etoricoxib Sales (2021-2032) & (K Units) Figure 5. 120 mg Image Figure 6. Global 120 mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 30 mg Image Figure 8. Global 30 mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 60 mg Image Figure 10. Global 60 mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 90 mg Image Figure 12. Global 90 mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Etoricoxib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Etoricoxib Market Share by Type 2025 VS 2032 Figure 15. North America Etoricoxib Sales Market Share in Volume by Type in 2025 Figure 16. North America Etoricoxib Sales Market Share in Value by Type in 2025 Figure 17. Europe Etoricoxib Sales Market Share in Volume by Type in 2025 Figure 18. Europe Etoricoxib Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Etoricoxib Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Etoricoxib Sales Market Share in Value by Type in 2025 Figure 21. Latin America Etoricoxib Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Etoricoxib Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Etoricoxib Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Etoricoxib Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Etoricoxib Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Etoricoxib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Etoricoxib Market Share by Application 2025 VS 2032 Figure 35. North America Etoricoxib Sales Market Share in Volume by Application in 2025 Figure 36. North America Etoricoxib Sales Market Share in Value by Application in 2025 Figure 37. Europe Etoricoxib Sales Market Share in Volume by Application in 2025 Figure 38. Europe Etoricoxib Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Etoricoxib Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Etoricoxib Sales Market Share in Value by Application in 2025 Figure 41. Latin America Etoricoxib Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Etoricoxib Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Etoricoxib Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Etoricoxib Sales Market Share in Value by Application in 2025 Figure 45. North America Etoricoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Etoricoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Etoricoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Etoricoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Etoricoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Etoricoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Etoricoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Etoricoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Etoricoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Etoricoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Etoricoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Etoricoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Etoricoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Etoricoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Etoricoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Etoricoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Etoricoxib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Etoricoxib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Etoricoxib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Etoricoxib Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Etoricoxib Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Etoricoxib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 120 mg
  • 30 mg
  • 60 mg
  • 90 mg
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Shanghai Shyndec Pharmaceutical
  • Qilu Pharmaceutical
  • Merck & Co
  • Easton Biopharmaceuticals
  • Beijing Tide Pharmaceutical
  • Morepen Laboratories
  • Metrochem API
  • Hema Pharmaceuticals
  • Frosst Iberica SA
  • Atom Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Etoricoxib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Etoricoxib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Etoricoxib Market by Type
  6. 1.3.1 120 mg
  7. 1.3.2 30 mg
  8. 1.3.3 60 mg
  9. 1.3.4 90 mg
  10. 1.4 Global Etoricoxib Market Size by Type
  11. 1.4.1 Global Etoricoxib Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Etoricoxib Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Etoricoxib Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Etoricoxib Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Etoricoxib Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Etoricoxib Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Etoricoxib Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Etoricoxib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Etoricoxib Industry Trends
  2. 2.2 Etoricoxib Industry Drivers
  3. 2.3 Etoricoxib Industry Opportunities and Challenges
  4. 2.4 Etoricoxib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Etoricoxib Revenue (2021-2026)
  2. 3.2 Global Top Players by Etoricoxib Sales (2021-2026)
  3. 3.3 Global Top Players by Etoricoxib Price (2021-2026)
  4. 3.4 Global Etoricoxib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Etoricoxib Major Company Production Sites & Headquarters
  6. 3.6 Global Etoricoxib Company, Product Type & Application
  7. 3.7 Global Etoricoxib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Etoricoxib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Etoricoxib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Etoricoxib Tier 1, Tier 2, and Tier 3
4 Etoricoxib Regional Status and Outlook
  1. 4.1 Global Etoricoxib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Etoricoxib Historic Market Size by Region
  3. 4.2.1 Global Etoricoxib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Etoricoxib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Etoricoxib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Etoricoxib Forecasted Market Size by Region
  7. 4.3.1 Global Etoricoxib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Etoricoxib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Etoricoxib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Etoricoxib by Application
  1. 5.1 Etoricoxib Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Etoricoxib Market Size by Application
  6. 5.2.1 Global Etoricoxib Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Etoricoxib Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Etoricoxib Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Etoricoxib Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Etoricoxib Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Etoricoxib Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Etoricoxib Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Etoricoxib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Shyndec Pharmaceutical
  2. 6.1.1 Shanghai Shyndec Pharmaceutical Company Information
  3. 6.1.2 Shanghai Shyndec Pharmaceutical Business Overview
  4. 6.1.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio
  6. 6.1.5 Shanghai Shyndec Pharmaceutical Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Etoricoxib Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Merck & Co
  14. 6.3.1 Merck & Co Company Information
  15. 6.3.2 Merck & Co Business Overview
  16. 6.3.3 Merck & Co Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co Etoricoxib Product Portfolio
  18. 6.3.5 Merck & Co Recent Developments
  19. 6.4 Easton Biopharmaceuticals
  20. 6.4.1 Easton Biopharmaceuticals Company Information
  21. 6.4.2 Easton Biopharmaceuticals Business Overview
  22. 6.4.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Easton Biopharmaceuticals Etoricoxib Product Portfolio
  24. 6.4.5 Easton Biopharmaceuticals Recent Developments
  25. 6.5 Beijing Tide Pharmaceutical
  26. 6.5.1 Beijing Tide Pharmaceutical Company Information
  27. 6.5.2 Beijing Tide Pharmaceutical Business Overview
  28. 6.5.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Tide Pharmaceutical Etoricoxib Product Portfolio
  30. 6.5.5 Beijing Tide Pharmaceutical Recent Developments
  31. 6.6 Morepen Laboratories
  32. 6.6.1 Morepen Laboratories Company Information
  33. 6.6.2 Morepen Laboratories Business Overview
  34. 6.6.3 Morepen Laboratories Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Morepen Laboratories Etoricoxib Product Portfolio
  36. 6.6.5 Morepen Laboratories Recent Developments
  37. 6.7 Metrochem API
  38. 6.7.1 Metrochem API Company Information
  39. 6.7.2 Metrochem API Business Overview
  40. 6.7.3 Metrochem API Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Metrochem API Etoricoxib Product Portfolio
  42. 6.7.5 Metrochem API Recent Developments
  43. 6.8 Hema Pharmaceuticals
  44. 6.8.1 Hema Pharmaceuticals Company Information
  45. 6.8.2 Hema Pharmaceuticals Business Overview
  46. 6.8.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hema Pharmaceuticals Etoricoxib Product Portfolio
  48. 6.8.5 Hema Pharmaceuticals Recent Developments
  49. 6.9 Frosst Iberica SA
  50. 6.9.1 Frosst Iberica SA Company Information
  51. 6.9.2 Frosst Iberica SA Business Overview
  52. 6.9.3 Frosst Iberica SA Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Frosst Iberica SA Etoricoxib Product Portfolio
  54. 6.9.5 Frosst Iberica SA Recent Developments
  55. 6.10 Atom Pharma
  56. 6.10.1 Atom Pharma Company Information
  57. 6.10.2 Atom Pharma Business Overview
  58. 6.10.3 Atom Pharma Etoricoxib Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Atom Pharma Etoricoxib Product Portfolio
  60. 6.10.5 Atom Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Etoricoxib Sales by Country
  2. 7.1.1 North America Etoricoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Etoricoxib Sales by Country (2021-2026)
  4. 7.1.3 North America Etoricoxib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Etoricoxib Market Size by Country
  6. 7.2.1 North America Etoricoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Etoricoxib Market Size by Country (2021-2026)
  8. 7.2.3 North America Etoricoxib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Etoricoxib Sales by Country
  2. 8.1.1 Europe Etoricoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Etoricoxib Sales by Country (2021-2026)
  4. 8.1.3 Europe Etoricoxib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Etoricoxib Market Size by Country
  6. 8.2.1 Europe Etoricoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Etoricoxib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Etoricoxib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Etoricoxib Sales by Country
  2. 9.1.1 Asia-Pacific Etoricoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Etoricoxib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Etoricoxib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Etoricoxib Market Size by Country
  6. 9.2.1 Asia-Pacific Etoricoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Etoricoxib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Etoricoxib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Etoricoxib Sales by Country
  2. 10.1.1 South America Etoricoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Etoricoxib Sales by Country (2021-2026)
  4. 10.1.3 South America Etoricoxib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Etoricoxib Market Size by Country
  6. 10.2.1 South America Etoricoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Etoricoxib Market Size by Country (2021-2026)
  8. 10.2.3 South America Etoricoxib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Etoricoxib Sales by Country
  2. 11.1.1 Middle East and Africa Etoricoxib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Etoricoxib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Etoricoxib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Etoricoxib Market Size by Country
  6. 11.2.1 Middle East and Africa Etoricoxib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Etoricoxib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Etoricoxib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Etoricoxib Value Chain Analysis
  2. 12.1.1 Etoricoxib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Etoricoxib Production Mode & Process
  7. 12.2 Etoricoxib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Etoricoxib Distributors
  10. 12.2.3 Etoricoxib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst